Method of treatment for premature rupture of membranes in pregnancy (PROM)

Patent Citations (36)

Non-Patent Literature (56)

• Akala, E.O. et al., “Novel pH-sensitive hydrogels with adjustable swelling kinetics,” Biomaterials, 19:1037-1047 (1998).Applicant
• Alleyne et al., “Efficacy and biocompatibility of a photopolymerized, synthetic, absorbable hydrogel as a dural sealant in a canine craniotomy model,” J. Neurosurg., 88:308-313 (1998).Applicant
• Andreopoulos et al., “Release of Drugs from Polymeric Hydrogels,” J. Biomater. Appls., 12:291-99 (1998).Applicant
• Anseth et al., “Mechanical properties of hydrogels and their experimental determination,” Biomaterials, 17:1647-57 (1996).Applicant
• Blanco et al., “Slow releasing of ara-C from poly(2-hydroxyethyl methacrylate) and poly(2-hydroxyethyl methacrylate-co-N-vinyl-2-pyrrolidone) hydrogels implanted subcutaneously in the back of rats,” Biomaterials, 19:861-69 (1998).Applicant
• Blue et al., “In Vivo Results of Hydrogel Composite Pericardial Substitutes,” ASAIO Transactions, 37:M152-53 (1991).Applicant
• Chetoni et al., “Silicone rubber/hydrogel composite ophthalmic inserts: preparation and preliminary in vitro/in vivo evaluation,” Eur. J. Pharm. Biopharm., 46:125-32 (1998).Applicant
• Cífková et al., “Silicone rubber-hyrogel composites as polymeric biomaterials,” Biomaterials, 11:393-396 (1990).Applicant
• Corkhill et al., “Synthetic hydrogels VI. Hydrogel composites as wound dressings and implant materials,” Biomaterials, 10:3-10 (1989).Applicant
• Draye et al., “In vitro release characteristics of bioactive molecules from dextran dialdehyde cross-linked gelatin hydrogel films,” Biomaterials, 19:99-107 (1998).Applicant
• Gomez et al., “Poly(acrylamide-co-monoethyl Itaconate) Hydrogels as Devices for Cytarabine Release in Rats,” J. Pharm. Pharmacol. 50:703-712 (1998).Applicant
• Hoffman, “‘Intelligent’ Polymers in Medicine and Biotechnology,” Artificial Organs, 19(5):458-467 (1995).Applicant
• Hong et al., “Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution,” J. Biomater. Sci. Polym. Ed., 9(9):1001-1014 (1998).Applicant
• Horák et al., “Hydrogels in endovascular embolization,” Biomaterials, 9:367-371 (1988).Applicant
• Iza et al., “Hydrogels of poly(ethylene glycol): mechanical characterization and release of a model drug,” J. Controlled Release, 52:41-51 (1998).Applicant
• Kikkinides et al., “A two-phase model for controlled drug release from biphasic polymer hydrogels,” J. Controlled Release, 51:313-325 (1998).Applicant
• Lopour et al., “Silicone rubber-hydrogel composites as polymeric biomaterials,” Biomaterials, 11:397-402 (1990).Applicant
• Martin et al., “Highly swelling hydrogels from ordered galactose-based polyacrylates,” Biomaterials, 19:69-76 (1998).Applicant
• Merrill et al., Partitioning and diffusion of solutes in hydrogels of poly(ethylene oxide) Biomaterials, 14(15):1117-26 (1993).Applicant
• Nakayama et al., “Surface Fixation of Hydrogels Heparin and Glucose Oxidase Hydrogelated Surfaces,” ASAIO Journal, 38:M421-24 (1992).Applicant
• Oxley et al., “Macroporous hydrogels for biomedical applications: methodology and morphology,” Biomaterials, 14:1064-72 (1993).Applicant
• Ranger et al., “Pneumostasis of Experimental Air Links with a New Photopolymerized Synthetic Tissue Sealant,” Am. Surg., 63(9):788-795 (Sep., 1997).Applicant
• Slepian et al., “Polymeric Endoluminal Gel Paving: Therapeutic Hydrogel Barriers and Sustained Drug Delivery Depots for Local Arterial Wall Biomanipulation,” Semin. Intervent. Cardiol., 1:103-16 (1996).Applicant
• Slepian, “Polymeric Endoluminal Paving and Sealing: Therapeutic at the Crossroad of Biomechanics and Pharmacology,” Section IV, Chapter 32, pp. 647-670.Applicant
• Suggs et al., “Preparation and characterization of poly(propylene fumarate-co-ethylene glycol) hydrogels,” J. Biomater. Sci. Polym. Edn., 9(7):653-66 (1998).Applicant
• Tabata et al., “Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels,” Biomaterials, 19:807-815 (1998).Applicant
• Tay et al., “Activity toward thrombin-antithrombin of heparin immobilized on two hydrogels,” Biomaterials, 10:11-15 (1989).Applicant
• Trigo et al., “Anticancer drug, ara-C, release from pHEMA hydrogels,” Biomaterials, 15(14):1181-86 (1994).Applicant
• Watler et al., “Water content and compression modulus of some heparin-PVA hydrogels,” Biomaterials, 9:150-54 (1988).Applicant
• Yamamoto et al., “Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein,” J. Biomater. Sci. Polymer Edn., 9(5):439-458 (1998).Applicant
• Allen and Jones, “Medical Complications of Prematurity,” Obstetrics and Gynecology, vol. 67, No. 3, (3/86), pp. 427-437.Applicant
• Baumgarten and Moser, “The Technique of Fibrin Adhesion for Premature Rupture of the Membranes During Pregnancy,” J. Perinat. Med.; 14 (1986), pp. 43-49.Applicant
• Bonnett et al., “Effect of Endoscopic Light on Developing Rat Retina,” Fetal Diagnosis and Therapy, No. 12, pp. 76-80 (1997).Applicant
• Evans et al., “Fetal Muscle Biopsy: Collaborative Experience with Varied Indications,” Obstetrics and Gynecology, vol. 84, No. 6, pp. 913-917, (12/94).Applicant
• Evans et al., “Endoscopically Assisted Ultrasound—Guided Fetal Muscle Biopsy,” Fetal-Diagnosis and Therapy, No. 10, 167-172, (1995).Applicant
• Gibbs and Blanco, “Premature Rupture of the Membranes,” Obstetrics and Gynecology, vol. 60, No. 6, pp. 671-679, (Dec. 1982).Applicant
• Gunn et al., “Premature Rupture of the Fetal Membranes,” Amer. J. Obstet. Gynec., vol. 106, No. 3, pp. 469-483, (Feb. 1, 1970).Applicant
• Harriman, “Tenacity and Glue Save Pregnancy,” Copyright 1997, The New Journal Co.Applicant
• Johnson et al., “Premature Rupture of the Membranes and Prolonged Latency,” Obstetrics and Gynecology, vol. 57, No. 5, pp. 547-556, (May 1981).Applicant
• Lewis et al. “Effects of Digital Vaginal Examinations on Latency Period in Pretern Rupture of Membranes,” Obstetrics and Gynecology, vol. 80, No. 4, pp. 630-634, (Oct. 1992).Applicant
• Louis-Sylvestre et al., “In Vitro Studies of the Interactions Between Platlets and Amniotic Membranes; A Potential Treatment for Pretern Premature Rupture of the Membranes,” Am. J. Obstet. Gynecol, vol. 178, No. 2, pp. 287-293, (Feb. 1998).Applicant
• Maxwell, “Pretern Premature Rupture of Membranes,” Obstetrical and Gyncological Survey, vol. 48, No. 10, pp. 576-583, Copyright © 1993 by Williams & Wilkins.Applicant
• Ogita et al., “Premature Rupture of the Membranes Managed With a New Cervical Catheter,” The Lancet, p. 1330, (Jun. 16, 1984).Applicant
• Ogita et al., “Transcervical Amnioinfusion of Antibiotics: A Study for Managing Premature Rupture of Membranes,” Am. J. Obstet. Gynecol., vol. 158, No. 1, pp. 23-27, (Jan. 1998).Applicant
• Ogita et al., “Clinical Effectiveness of a New Cervical Indwelling Catheter in the Management of Premature Rupture of the Membranes: A Japanese Collaborative Study,” Am. J. Obstet. Gynecol., vol. 159, No. 2, pp. 336-341, (Aug. 1988).Applicant
• Parry and Strauss III, “Premature Rupture of the Fetal Membranes,” New England Journal of Medicine, vol. 338, No. 10, pp. 663-670, (Mar. 5, 1998).Applicant
• Quintero et al., “In-utero Percutaneous Cytoscopy in the Management of Fetal Lower Obstructive Uropathy,” The Lancet, vol. 346, pp. 537-540, (Aug. 26, 1995).Applicant
• Quintero et al., “Hydrolaparoscopy in the Rabbit: A Fine Model for the Development of Operative Fetoscopy,” Am. J. Obstet. Gynecol, vol. 171, No. 4, pp. 1139-1142, (Oct. 1994).Applicant
• Quintero et al., “Percutaneous Fetal Cytoscopy and Endoscopic Fulguration of Posterior Urethral Valves,” Am. J. Obstet. Gynecol., vol. 172, No. 1, Part 1, pp. 206-209, (Jan. 1995).Applicant
• Quintero et al., “Repair Kinetics of Amnion Cells After Microsurgical Injury,” Fetal Diagn. Ther., No. 11, pp. 348-356, (1996).Applicant
• Quintero et al., “Effect of Endoscopic White Light on the Developing Visual Pathways A Histologic, Histochemical, and Behavioral Study,” Am. J. Obstet. Gynecol., vol. 171, No. 4, pp. 1142-1148, (Oct. 1994).Applicant
• Rubén et al., “Embryoscopy and Fetoscopy, Prenatal Diagnosis: Present and Future Perspectives,” vol. 20, No. 3, pp. 563-581, (Sep. 1993).Applicant
• Taylor and Garite, “Premature Rupture of Membranes Before Fetal Viability,” Obstetrics & Gynecology, vol. 64, No. 5, pp. 615-620, (Nov. 1984).Applicant
• Uchide et al., “Intracervical Fibrin Instillation as an Adjuvant to Treatment for Second Trimester Rupture of Membranes,” Arch. Gynecol. Obstet., vol. 255, pp. 95-98, (1994).Applicant
• Harmanli, et al., “Efficacy of Fibrin Glue for in Vitro Sealing of Human Chorioamniotic Membranes” The Journal of Reproductive Medicine, Inc. vol. 43, No. 11/Nov. 1998 pp. 986-990.Applicant
• Vergamo et al., “Amnioinfusion for Prevention of Pulmonary Hypoplasia in Second-Trimester Rupture of Pulmonary Hypoplasia in Second-Trimester Rupture of Membranes,” American Journal of Perinatology, vol. 14, No. 6, pp. 325-329, Jul. 1997.Applicant